Metabolic aspects of myocardial disease and a role for L-carnitine in the treatment of childhood cardiomyopathy.

Abstract

OBJECTIVES A multicenter retrospective study was conducted to investigate the possible metabolic causes of pediatric cardiomyopathy and evaluate the outcome of patients treated with L-carnitine. METHODS Seventy-six patients diagnosed with cardiomyopathy were treated with L-carnitine in addition to conventional cardiac treatment, and 145 patients were… (More)

Topics

Cite this paper

@article{Helton2000MetabolicAO, title={Metabolic aspects of myocardial disease and a role for L-carnitine in the treatment of childhood cardiomyopathy.}, author={Erin Helton and Robert K. Darragh and Peggy Francis and Frederick Jay Fricker and Kaitlin Jue and Gary G. Koch and Dora Mair and Mary Ella Pierpont and James V Prochazka and Lawrence S. Linn and Susan C. Winter}, journal={Pediatrics}, year={2000}, volume={105 6}, pages={1260-70} }